Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with ...
The FDA has approved lerodalcibep-liga, a third-generation injectable PCSK9 inhibitor, to reduce LDL cholesterol in adults ...
An experimental pain-relieving drug delivery method for farm animals using microneedle patches may not have delivered an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback